CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking-Reference-Cited by-同舟云学术

CB1 receptor neutral antagonist treatment epigenetically increases neuropeptide Y expression and decreases alcohol drinking

Published:2021-09 Issue: Volume:195 Page:108623
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Dulman Russell S.,Zhang Huaibo,Banerjee Ritabrata,Krishnan Harish R.^ORCID,Dong Bin,Hungund Basalingappa L.,Vinod K. Yaragudri,Pandey Subhash C.^ORCID

Funder

National Institute on Alcohol Abuse and Alcoholism

U.S. Department of Veterans Affairs

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference86 articles.

1. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids;Bacci;Nature,2004

2. Cannabinoid-1 receptor neutral antagonist reduces binge-like alcohol consumption and alcohol-induced accumbal dopaminergic signaling;Balla;Neuropharmacology,2018

3. The CBP co-activator is a histone acetyltransferase;Bannister;Nature,1996

4. Hippocampal focal knockout of CBP affects specific histone modifications, long-term potentiation, and long-term memory;Barrett;Neuropsychopharmacology,2011

5. Emerging role of epigenetic mechanisms in alcohol addiction;Berkel;Alcohol Clin. Exp. Res.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. The neutral CB1 antagonist AM6527 reduces ethanol seeking, binge-like consumption, reinforcing, and withdrawal effects in male and female mice;Psychopharmacology;2023-11-25

3. Phenylbutyric acid robustly increases Npy mRNA expression in hypothalamic neurons by increasing H3K9/14 acetylation at the Npy promoter;Biochemical and Biophysical Research Communications;2023-05